Sofinnova Investments, Inc.

Position in PHVS — Pharvaris N.V.

CIK 1631134 Menlo Park, CA

Position in PHVS

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$30,475,319

+$7,357,553 QoQ

Shares Held

881,299

+7.7% QoQ

Ownership

1.26%

of shares outstanding

% of Portfolio

1.63%

of 13F equity value

Holder Rank

#16

of 124 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Sofinnova Investments, Inc. holds $1,182,454,857 across 43 Biotechnology names. PHVS ranks #17 (2.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VERA	Vera Therapeutics, Inc.	2,793,987	$119,889,982
2	GMAB	Genmab A/S	4,045,215	$111,122,056
3	JAZZ	Jazz Pharmaceuticals plc	365,341	$88,036,220
4	RAPP	Rapport Therapeutics, Inc.	1,904,408	$79,356,681
5	SPTX	Seaport Therapeutics, Inc.	3,564,871	$77,428,998
6	AVBP	ArriVent BioPharma, Inc.	1,696,752	$58,945,164
7	RARE	Ultragenyx Pharmaceutical Inc.	1,717,505	$57,347,491
8	RYTM	Rhythm Pharmaceuticals, Inc.	408,027	$45,303,237

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$30,475,319	881,299	+7.7%	Shares	Sole	2026-08-14
2026-03-31	$23,117,766	818,328	+9.8%	Shares	Sole	2026-05-15
2025-12-31	$20,678,439	745,169	+0.7%	Shares	Sole	2026-02-13
2025-09-30	$18,459,906	739,876	+26.4%	Shares	Sole	2025-11-14
2025-06-30	$10,305,363	585,532	-1.3%	Shares	Sole	2025-08-14
2025-03-31	$9,316,427	593,403	+5.8%	Shares	Sole	2025-05-15
2024-12-31	$10,749,059	560,723	-6.6%	Shares	Sole	2025-02-14
2024-09-30	$11,117,593	600,302	-0.2%	Shares	Sole	2024-11-13
2024-06-30	$11,308,839	601,534	+2.9%	Shares	Sole	2024-08-09
2024-03-31	$13,511,769	584,672	+14.5%	Shares	Sole	2024-08-14
2023-12-31	$14,317,870	510,441	—	Shares	Sole	2024-08-15
No filing history on record for this holder in this stock.